Skip to content

To evaluate the effect of local anaesthetic in breast surgeries

Evaluation and efficacy of tumescent anesthesia in simple breast surgeries - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071679
Enrollment
30
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Evaluating the efficacy of local anaesthetic: Evaluating the efficacy of tumescent anaesthetic solution consisting of Lignocaine 2% 20 ml, Ropivacaine 0.75% 20 ml, Adrenaline 1:1000 1 m

Sponsors

Vinayaka Missions Kirupananda Variyar Medical College and Hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA Grade 1 & 2 2. Age not less than 15 years and not more than 50 years 3. Elective surgeries 4. Operable breast surgeries 5. Patient giving valid informed consent

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. ASA Grade 3 & 4 3. Age less than 15 years and more than 50 years 4. Carcinoma breast 5. Local infection at puncture site 6. Patient with ischaemic and rheumatic heart diseases 7. Patient with coagulation defects and on anti coagulants 8. Patients with neuromuscular disorder 9. Patients allergic to local anaesthetic drugs

Design outcomes

Primary

MeasureTime frame
To determine the efficacy of surgical anaesthesia for simple breast surgeries using tumescent techniqueTimepoint: 2 to 4 hours

Secondary

MeasureTime frame
To assess the post operative analgesic duration of anaesthesiaTimepoint: 24 hours

Countries

India

Contacts

Public ContactDr G John Peter

Vinayaka Missions Kirupananda Variyar Medical College and Hospitals Chinnaseeragapadi Salem

naveenasen@gmail.com9486198407

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026